Natural vs Lab-Grown Diamonds
How laboratory-grown diamonds are made, why they are chemically identical to natural stones, and how the two markets have diverged into separate pricing economies.
The biggest structural change in the diamond trade over the last decade has nothing to do with the 4 Cs, cutting technology, or consumer preference. It has to do with where the crystals come from. Laboratory-grown diamonds — physically and optically indistinguishable from natural stones — have moved from specialty novelty to mainstream inventory in roughly ten years, and in the process they have split the market into two separate pricing economies that barely reference each other.
For anyone buying, selling, or valuing diamonds today, understanding this split is not optional. The question "is it natural or lab?" is the single largest price determinant on any lot.
How lab-grown diamonds are made
Two production technologies dominate the market, and the trade is increasingly interested in which method produced a given stone because the optical characteristics drift subtly between them.
HPHT — High Pressure, High Temperature. The original industrial process, in commercial use since the 1950s for industrial-grade diamonds and since the 2000s for gem quality. A metal flux (typically iron-nickel-cobalt) is heated above 1400°C and pressurised to roughly 55 kilobars in a specialised press. A tiny diamond seed is placed in the chamber; carbon dissolves in the molten metal and recrystallises on the seed over several weeks. The process replicates the geological conditions under which natural diamonds form, at an industrially-useful speed. HPHT stones tend to have distinctive cuboctahedral growth patterns and sometimes pick up trace metal inclusions from the flux.
CVD — Chemical Vapour Deposition. The technology that reshaped the commercial lab-grown market in the 2010s. A diamond seed is placed in a low-pressure microwave plasma reactor filled with hydrogen and methane. Microwaves dissociate the methane; carbon atoms deposit on the seed layer by layer, growing the crystal from the surface upward. CVD is cheaper to scale, produces larger crystals more easily, and has dominated gem-grade lab-grown production for commercial sizes. CVD stones grow in flat tabular layers (parallel to the seed surface) and can show characteristic strain patterns under cross-polarisation.
Both methods produce chemically pure crystalline carbon. The industrial distinction matters to gemologists detecting origin, but for most trade purposes the end-user sees a diamond — indistinguishable from natural by eye or by conventional loupe inspection.
Why detection is not a consumer-level problem
Every major laboratory uses specialised instruments to distinguish lab-grown from natural. The physics rely on subtle differences: slight variations in trace nitrogen content, growth-pattern strain visible under cross-polarisation, fluorescence signatures under short-wave UV, and phosphorescence characteristics that differ between natural and synthetic origins.
The practical consequence for the trade:
- A certified stone — one with a grading report from GIA, IGI, HRD, or another major lab — is reliably identified as natural or lab-grown. The lab does this as part of grading and it appears on the report
- An uncertified stone cannot be reliably distinguished in hand without specialised equipment. A jeweller with a diamond tester can confirm it is diamond, but the tester cannot say whether it is natural or synthetic. The consumer cannot tell at all
- Detection equipment (De Beers Automated Melee Screening, GIA's iD100, Yehuda Sherlock, and similar) is commercially available for larger operators but is an investment most small-volume traders do not make
The trade response has been to insist on certification for any stone above about 0.20 ct. For mêlée (parcels of tiny stones) the risk of synthetic contamination is a known concern, and trade-grade detection screening is increasingly standard for wholesalers handling large parcels.
The price divergence
The single most important commercial fact about lab-grown diamonds: they are not priced as a discount to natural. They are priced in an entirely separate market that happens to cover the same grade ladder.
At 1.00 ct, lab-grown prices at roughly 12% of the natural equivalent. The gap widens with weight — natural rises sharply at 1, 2, and 3 ct thresholds while lab-grown stays nearly flat.
Illustrative curves for F colour, VS1 clarity, Excellent cut. Lab-grown wholesale prices have been falling roughly 10–20% per year since 2022 and the curves shown here reflect 2024–2025 levels; the actual gap changes continuously with production capacity and demand.
Walk the slider across the weight range. Two observations the chart makes tangible:
- The gap is enormous at every weight. Lab-grown stones trade at roughly 5–25% of the natural per-carat price depending on size. At 1 ct the gap is around 10–15×; at 3 ct it opens to 12–15× or more
- The gap widens with weight. Natural prices rise sharply at weight thresholds — 1 ct, 2 ct, 3 ct each trigger non-linear price jumps driven by rough scarcity. Lab-grown prices stay nearly flat as weight increases because the production cost of a 3 ct CVD stone is not three times higher than a 1 ct — the same reactor grows larger crystals in slightly more time
This divergence has been widening, not narrowing. The reason is production economics.
Why lab-grown prices keep falling
Natural diamonds come out of a finite geological resource. Their price is driven by discovery, mining cost, De Beers' historical supply management, and global demand. Supply grows slowly and with significant lead times.
Lab-grown diamonds come out of reactors. Each new reactor commissioned adds directly to global production capacity, and the marginal cost of another carat drops as reactor technology improves. Over the last decade:
- Production capacity has expanded dramatically, primarily in China and India, as CVD reactor designs have matured and scaled
- Per-carat production cost has fallen as reactors have grown, yield has improved, and electricity costs have been optimised. Some producers now report wholesale break-even below $200/ct for commercial-grade goods
- Wholesale prices have dropped roughly 10–20% per year since 2022. The rate has varied by size and quality band, but the direction has been consistent
The consequence: a lab-grown diamond purchased at retail in 2022 is worth materially less today as a secondhand good than when it was bought. A natural diamond purchased at the same time has held or appreciated. This is not a moral judgement — it is the arithmetic of an industrially-produced good versus a finite geological one.
Resale asymmetry
The divergence in new-goods pricing is dramatic but not the full story. The resale gap is even wider.
- Natural diamonds retain roughly 30–50% of retail price on the secondhand market, depending on size, quality, and market timing. Top-end goods (3 ct+, D-F, VS1+) hold up better; commercial goods drop more
- Lab-grown diamonds retain roughly 0–20% of retail price on the secondhand market, and the percentage is still falling. There is no meaningful secondary market for lab-grown — resale is almost always a liquidation
The reason is supply continuity. A buyer of a used natural diamond knows the supply is fixed and the stone retains some reference price. A buyer of a used lab-grown knows that next year's production run will be cheaper still, which creates a deflationary expectation on all existing stock. The prospect of the same stone being obtainable new at a lower price caps any secondhand bid.
Commercial implications
For retail buyers, the lab-grown proposition is simple: a visually equivalent stone at 10–20% of the natural price. If the buyer is indifferent to geological origin and secondary-market value, the lab-grown offer is compelling. Most of the lab-grown growth in the last five years has come from buyers who explicitly make this trade-off.
For wholesale dealers and inventory managers, the calculus is very different:
- Lab-grown inventory depreciates continuously. Holding periods matter. Goods that sit for six months lose meaningful value; goods that sit for a year may be unsellable at cost
- Natural inventory holds value. Traditional carrying costs apply but the underlying asset is stable
- Mixing inventories is dangerous. An accounting system that marks all diamonds at a common margin will under-reserve lab-grown and over-reserve natural. Separate tracking is essential
For price discovery, the two markets barely interact. Changes in lab-grown prices do not meaningfully affect natural pricing on short time horizons. Over a multi-year horizon there may be some demand substitution at the commercial end of the natural market (sub-1ct commercial goods), but top-segment natural goods (>2ct, D-F, VS1+) are effectively insulated.
Certification and disclosure
Since 2007, GIA has grading reports specifically for laboratory-grown diamonds. These reports use the same grading protocols as natural reports but are clearly marked "Laboratory-Grown Diamond" and include the production method (HPHT or CVD) when detectable. IGI, HRD, GCAL, and other major laboratories offer similar dedicated reports.
Disclosure has been the central regulatory issue. Both the US Federal Trade Commission and the Indian government have rules requiring clear labelling of lab-grown stones at every point in the supply chain. In practice:
- Parcel-level disclosure is mandatory and well-enforced in legitimate trade channels. Lab-grown mêlée is sold as lab-grown
- Individual stone disclosure is mandatory on any certificate above ~0.20 ct
- Mixed parcels (natural and lab in the same lot) are a persistent concern. The trade assumption is that any parcel not explicitly tested for origin could contain synthetic contamination at small sizes
The enforcement gap is largely at the retail end, where the consumer relies on the seller's disclosure. For B2B sourcing, trade rules plus certification close most of the risk — but any buyer working through unfamiliar supply channels should screen for synthetic contamination as standard practice.
Practical sourcing notes
- Always buy certified. For natural goods this has always been best practice; for lab-grown it is non-negotiable because the production method affects pricing and because the stone's origin determines which market it trades in
- Segregate inventory accounting. Keep natural and lab-grown books separate. Do not compute blended margin, do not apply blended carrying costs, and do not benchmark one against the other
- Hold natural, turn lab. The optimal holding strategy is the opposite for the two categories. Natural goods justify longer hold periods because they appreciate or hold value; lab-grown goods should be sold quickly before the next price drop. Treat lab-grown as a working-capital product, not an asset
- Track lab-grown wholesale benchmarks, not retail. Retail prices for lab-grown are heavily marketing-driven and do not track wholesale accurately. The wholesale number — what you can replace the stone for tomorrow — is the only one that matters for inventory valuation
- Watch the CVD-to-HPHT ratio. CVD production has gained share rapidly and now accounts for most gem-quality lab-grown output. Supply mix shifts between the two technologies affect quality distribution and pricing